JPEF Mini CME, January 2025

The JPEF Mini CME – January 2025 was successfully conducted on January 29, 2025, at Residency Tower, Trivandrum. Organized by Jothydev’s Professional Education Forum (JPEF) in association with P. Kesavadev Trust and IMA Nemom, the event provided a valuable platform for healthcare professionals to engage in discussions on key aspects of diabetes care and clinical practice.

The scientific program featured three expert-led sessions, each covering an essential topic in diabetes management and related conditions. The first session, “Antibiotic Use in People with Diabetes: Clinical Directions”, was delivered by Dr. Sumesh Raj. This session highlighted the rational use of antibiotics in people with diabetes, considering their increased risk of infections and the growing concern of antibiotic resistance. The discussion focused on clinical guidelines, antibiotic stewardship, and best practices to optimize infection management. The session was chaired by Dr. K. Balachandran and Dr. Ashwin David Ashok, who facilitated an engaging and insightful discussion among participants.

The second session, “Practical Guidelines for Early Management of MASLD”, was presented by Dr. Ajith Kumar S. This session provided a structured approach to the identification, risk assessment, and management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a condition of increasing clinical relevance in diabetes care. The session was chaired by Dr. Arun Shankar and Dr. Shahana Yasmin, who guided an interactive discussion, helping participants translate key insights into clinical practice.

The final session, “Case-Based Discussion on the Use of CGM and Cloud-Based Data”, was led by Dr. Jothydev Kesavadev. This interactive session explored real-world applications of Continuous Glucose Monitoring (CGM) and cloud-based data analytics in diabetes management. Through detailed case studies, participants learned how digital tools and remote monitoring can enhance glycemic control and patient outcomes. The session was chaired by Dr. Benny P. V and Dr. Devin Prabhakar, who facilitated an engaging conversation, ensuring practical takeaways for the attendees.

The CME witnessed excellent participation, with healthcare professionals actively engaging in discussions and sharing their clinical experiences. The case-based format made the sessions highly interactive, allowing attendees to apply evidence-based knowledge to practical scenarios. The involvement of expert faculty and chairpersons further enriched the learning experience, ensuring a well-rounded discussion on each topic.

Dr. Jothydev Kesavadev Quoted in Mathrubhumi Article on Inhaled Insulin

An article published in Mathrubhumi highlights the upcoming launch of inhaled insulin in India, marking a significant advancement in diabetes management. The piece features expert insights from Dr. Jothydev Kesavadev, who emphasizes the potential of inhaled insulin as a needle-free, rapid-acting option that can improve glucose control and enhance treatment adherence, especially for individuals with Type 1 and Type 2 diabetes.

Dr. Jothydev Kesavadev’s Article Featured in IMA Nammude Aarogyam – January 2025 Issue

The January 2025 issue of IMA Nammude Aarogyam (Our Health), a publication by the Indian Medical Association (IMA) dedicated to promoting public awareness of modern medical advancements, features an insightful article by Dr. Jothydev Kesavadev. In this article, Dr.Jothydev, highlights the latest advances in the treatment of Type 1 diabetes, shedding light on cutting-edge therapies and technologies that are transforming diabetes management. The piece offers valuable information for the public, emphasizing the importance of early intervention, innovative treatment strategies, and personalized care in improving outcomes for people living with Type 1 diabetes.

Video on Inhaled Insulin by Dr. Jothydev Kesavadev Published on Facebook

Dr. Jothydev Kesavadev has released an informative video on inhaled insulin, now available on his official Facebook page. In the video, Dr. Kesavadev discusses the upcoming introduction of inhaled insulin in India, highlighting its potential as a needle-free, rapid-acting alternative to traditional insulin injections.